CELH
Celsius Holdings, Inc.
CELH has the edge over CHGG overall, supported by stronger fundamentals and lower modeled downside.
CHGG
Chegg, Inc.
CHGG trails on the overall score without a compensating advantage in the available component scores.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CHGG Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Unavailable |
CHGG's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
CHGG PE Valuation
CHGG has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over CHGG on the outlook, with more favorable revenue expectations.
CHGG Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Improving | |
| Limited | |
| High |
Analysts expect CHGG's losses to shrink, with revenue declining.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over CHGG on earnings quality, reporting a profit while its opponent remains loss making.
CHGG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.37 | +$0.32 |
| Q2 2026 | -$0.49 | +$2.09 |
| Q1 2026 | -$0.79 | +$7.47 |
| Q4 2025 | -$0.96 | +$7.14 |
| Q3 2023 | -$0.24 | -115% |
| Q2 2023 | $1.15 | +203% |
| Q1 2023 | $1.32 | +154% |
| Q4 2022 | $1.34 | +$1.35 |
CHGG is still losing money, but far less than before: $0.37 per share over the past year, against $8.26 at its worst in early 2025.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over CHGG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over CHGG on profitability, with a higher operating margin.
CHGG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $46.5M | -40% |
| Q2 2026 | $51.8M | -51% |
| Q1 2026 | $63.3M | -48% |
| Q4 2025 | $72.7M | -49% |
| Q3 2025 | $77.7M | -43% |
| Q2 2025 | $105.1M | -36% |
| Q1 2025 | $121.4M | -30% |
| Q4 2024 | $143.5M | -24% |
CHGG's revenue has slid since its 2021 peak: $46M last quarter, down 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -11% | +11 points |
| Q2 2026 | -6.1% | +29 points |
| Q1 2026 | -1.6% | +22 points |
| Q4 2025 | -47% | -28 points |
| Q3 2025 | -22% | +141 points |
| Q2 2025 | -35% | +263 points |
| Q1 2025 | -24% | -23 points |
| Q4 2024 | -19% | -26 points |
CHGG's operating margin was −11% last quarter, up 11 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over CHGG on cash generation, producing positive trailing cash flow while its opponent burns cash.
CHGG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.5M | +$6.4M |
| Q2 2026 | $6.4M | +$18.5M |
| Q1 2026 | $3.1M | -81% |
| Q4 2025 | -$15.5M | -420% |
| Q3 2025 | -$943K | -104% |
| Q2 2025 | -$12.1M | -$8.5M |
| Q1 2025 | $15.9M | -37% |
| Q4 2024 | $4.8M | -91% |
CHGG's free cash flow has turned negative after years in the green: −$516,000 over the past year.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over CHGG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
CHGG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -397K shares |
| 1 year | +2.4% | +2.6M shares |
| 3 years | -3.8% | -4.4M shares |
| 5 years | -24% | -35.7M shares |
| Available history | -14% | -18.1M shares |
CHGG has 111M diluted shares, up 2.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2024 | $2.6M |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | $148.4M |
| Q3 2023 | — |
| Q2 2023 | $35.1M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
CHGG Net Leverage
CHGG's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
CHGG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.1 | Neutral |
| Stochastic | 10.5 | Oversold |
CHGG's weekly RSI is 36 (neutral) and its Stochastic is 10 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
CHGG PE vs Consumer Defensive Sector
| Metric | CHGG | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
CHGG has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over CHGG on trend strength, trading above more of its moving averages.
CHGG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.69 | 14% below |
| 20 week MA | $0.79 | 25% below |
| 50 week MA | $0.86 | 31% below |
| 100 week MA | $1.04 | 43% below |
| 200 week MA | $4.69 | 87% below |
CHGG is in a downtrend: it's below all five of its weekly moving averages, and 87% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over CHGG on returns for 2026, with the stronger performance.
CHGG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.2 | $92.4 | +142% |
| 2021 | $92.4 | $30.6 | -67% |
| 2022 | $30.6 | $26.0 | -15% |
| 2023 | $26.0 | $11.4 | -56% |
| 2024 | $11.4 | $1.58 | -86% |
| 2025 | $1.58 | $0.99 | -37% |
| 2026 YTD | $0.99 | $0.59 | -40% |
CHGG has finished five years in a row lower, and it's down 40% so far in 2026.